Evidence map›Paper›PMID 38164506›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2023

The Utility of ChatGPT in Diabetic Retinopathy Risk Assessment: A Comparative Study with Clinical Diagnosis.

Keerthana Raghu, Tamilselvi S, Chitralekha S Devishamani, Suchetha M, Ramachandran Rajalakshmi, Rajiv Raman

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Keerthana Raghu *Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Tamilselvi S *Centre for Health Care Advancement, Innovation, and Research Department, Vellore Institute of Technology, Chennai, Tamil Nadu, India.
Chitralekha S DevishamaniShri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Suchetha MCentre for Health Care Advancement, Innovation, and Research Department, Vellore Institute of Technology, Chennai, Tamil Nadu, India.
Ramachandran RajalakshmiDepartment of Diabetology, Ophthalmology and Epidemiology, Madras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialities Centre, Chennai, Tamil Nadu, India.ORCID 0000-0002-7063-6026
Rajiv RamanShri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Sankara Nethralaya · INVellore Institute of Technology University · INMadras Diabetes Research Foundation · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the ability of an artificial intelligence (AI) model, ChatGPT, in predicting the diabetic retinopathy (DR) risk. Methods: This retrospective observational study utilized an anonymized dataset of 111 patients with diabetes who underwent a comprehensive eye examination along with clinical and biochemical assessments. Clinical and biochemical data along with and without central subfield thickness (CST) values of the macula from OCT were uploaded to ChatGPT-4, and the response from the ChatGPT was compared to the clinical DR diagnosis made by an ophthalmologist. Results: The study assessed the consistency of responses provided by ChatGPT, yielding an Intraclass Correlation Coefficient (ICC) value of 0.936 (95% CI, 0.913-0.954, p < 0.001) (with CST) and 0.915 (95% CI, 0.706-0.846, p < 0.001) (without CST), both situations indicated excellent reliability. The sensitivity and specificity of ChatGPT in predicting the DR cases were evaluated. The results revealed a sensitivity of 67% with CST and 73% without CST. The specificity was 68% with CST and 54% without CST. However, Cohen's kappa revealed only a fair agreement between ChatGPT predictions and clinical DR status in both situations, with CST (kappa = 0.263, p = 0.005) and without CST (kappa = 0.351, p < 0.001). Conclusion: This study suggests that ChatGPT has the potential of a preliminary DR screening tool with further optimization needed for clinical use.

Indexed as

artificial intelligenceChatGPTdiabetesdiabetic retinopathy

Identifiers

PMID38164506
PMCPMC10758156
OpenAlexW4390350124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.